Last week a New York state court judge threw out claims by people who used Bausch & Lomb's ReNu Moisture Lock contact lens solution, ruling that plaintiffs had failed to show that their particular eye infections were caused by the product.

Asbestos plaintiffs who settled with Pfizer would have received payments contingent on the approval of a reorganization plan, which gave them an incentive to vote for the plan. That didn't sit well with Manhattan bankruptcy judge Stuart Bernstein.

Thirty-seven states are part of the settlement, which comes almost a year after the DOJ reached a similar, $520 million deal.

With summary judgment granted to AstraZeneca in another Seroquel case last week--the third Seroquel suit to be tossed on Daubert grounds--the Delaware state court judge overseeing a docket of 700 of the pharmaceutical product liability cases says it's time for plaintiffs' lawyers to consider the viability of the litigation.